Biotech | April 25, 2022
‘DREAM-ND’ and ‘DREAM-D’ Phase 3 trials of Desidustat published in American Journal of Nephrology
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
In this role, Romanelli will have P&L responsibility for Merck’s US $22 billion international human health business and lead a team of 14,000 colleagues in more than 75 markets outside of the U.S
Support for biologics manufacturability and Industry 4.0 initiatives
The report pointed out that in the process of treating Covid-19, there are promising data to suggest that TCM is beneficial in reducing the risk of progression from mild-to-moderate cases to severe Covid-19
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
The drug will be manufactured at the group's injectables manufacturing facility at Jarod, Gujarat
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award
New simplified structure and operational set-up supports Novartis strategy as a focused medicines company and is designed to power next phase of innovation, growth and productivity
Subscribe To Our Newsletter & Stay Updated
